scorecardresearch
Add as a preferred source on Google
Saturday, November 8, 2025
TopicCovid-19 treatment

Topic: Covid-19 treatment

Has Covid-19 strain evolved since it was first reported in India? ICMR study to find answer

After the lockdown, ICMR plans to ask all states and UTs to send positive Covid-19 samples to study the genetic diversity of the virus, which it says will help India prepare better.

This is how remdesivir, developed for Hepatitis C and Ebola, fights Covid-19

The experimental antiviral drug that was developed by US pharmaceutical company Gilead Sciences has shown that it leads to faster recovery in Covid-19 patients.

CSIR to test sepsis drug in asymptomatic Covid patients and those who have recovered

CSIR will launch trials to see if sepsis drug can stop Covid-19 from progressing in asymptomatic patients & if it can prevent it from redeveloping in recovered patients.

India to test Japanese flu drug favipiravir on Covid patients, Glenmark first to start trials

Favipiravir is among the drugs under trial for Covid-19 treatment along with anti-malarial medicine hydroxychloroquine and the Ebola drug remdesivir. 

How we’ve lost time in the race for a Covid-19 cure

Despite much hype around several existing drugs, we still haven’t found a proven, evidence-based treatment for Covid-19.

No green-zone in Delhi, Mirror on Mumbai’s ‘behemoth’ project & Mint, HT raise vaccine hopes

A round-up of the most important reports in major newspapers around the country – from TOI and HT, Express and The Hindu to The Telegraph, Mumbai Mirror and The Tribune, as well as top financial dailies.

Plasma therapy still in trial, cannot be used as Covid-19 treatment yet, says govt

The Union health ministry warned that using the plasma therapy to treat Covid-19 patients outside of a clinical trial will be considered illegal.

2 Indians join global remdesivir trial as the world pins its hopes on it to treat Covid-19

WHO is conducting Solidarity trial, for which about 1,650 patients have registered, to find treatment options for Covid-19.

Tablighis donate plasma, urge others to be donors as they look to put Covid controversy behind

Plasma therapy, which requires plasma from the blood of people who have recovered from Covid-19, has emerged as a promising treatment for the disease.

Don’t pin hopes on summer, social distancing still best Covid ‘vaccine’, says Harsh Vardhan

In an exclusive interview to ThePrint, Union Health Minister Harsh Vardhan also said the government is aiming to test one lakh people per day by 31 May.

On Camera

Trump’s unpredictability is not the absence of strategy—it works on everyone but China

The Italian term sprezzatura—a studied nonchalance that conceals intention—best captures the spirit of Trump’s foreign policy so far. The pattern is unpredictability, transactionalism, and disruption as diplomacy.

Asia’s ‘weakest’ link: Yunus on a tightrope as Bangladesh tries to fix banks without breaking economy

With 20.2 percent of its total loans in default by the end of last year, Bangladesh had the weakest banking system in Asia. Despite reforms, it will take time to recover.

‘Let them see’: Putin says new nuclear-powered missiles in the making, in message to Washington

At a ceremony felicitating Russian military engineers, Putin highlights Moscow’s 'parity' in defence technologies for the next century.

Bihar is where politics moves, and everything else stands still

Bihar is blessed with a land more fertile for revolutions than any in India. Why has it fallen so far behind then? Constant obsession with politics is at the root of its destruction.